Traveler’s Diarrhea Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Traveler’s Diarrhea Treatment Market is segmented by Drug Type (Antibiotics, Anti-diarrheal, and Other Drug Types), Distribution Channel (Hotel Pharmacies, Retail Pharmacies, and Other Distribution Channels), and Geography.

Market Snapshot

Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: North America
Largest Market: Asia Pacific
CAGR: 6.8 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The traveler’s diarrhea treatment market is expected to witness robust growth due to a surge in the number of travelers, rising awareness among travelers, and the availability of over-the-counter medications.

  • Traveler’s diarrhea affects millions of international travelers who travel to developing countries each year. Food and contaminated water are the primary sources of infection. Bacteria, such as E. coli and Salmonella, are the common causes of traveler’s diarrhea.
  • According to the World Tourism Organization (UNWTO), in 2019, around 1.5 billion international tourist arrivals were recorded, which was a 4% rise from 2018. The prevalence of traveler’s diarrhea is higher among travelers visiting regions in South Asia and Southeast Asia. The travel destination is the most significant risk factor for traveler’s diarrhea.
  • Hence, owing to these factors, the market is likely to witness significant growth during the forecast period. However, the side effects associated with the drugs are expected to impede the market growth.

Scope of the Report

As per the scope of the report, traveler's diarrhea is a digestive tract disorder characterized by an intestinal infection that occurs when a person consumes contaminated food and water. The market is categorized on the basis of drug type, distribution channel, and geography.

By Drug Type
Other Product Types
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Other Distribution Channels
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Retail Pharmacies Segment is Expected to Show Better Growth in the Forecast Years

Based on the distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and other distribution channels. A retail pharmacy refers to an independent pharmacy that has a state license to dispense medications to the general public. People are increasingly adopting retail pharmacies as a one-stop-shop to buy medicines. They are highly preferred by people who are unable to reach hospitals for a check-up on a regular basis and need medicine for quick treatment. The better outreach of retail pharmacies makes them a highly profitable segment and the most established one across several countries. Furthermore, the surge in the number of travelers is also expected to fuel the market growth during the forecast period.

Traveler’s Diarrhea Treatment Market 1

North America Holds the Largest Share in the Market

The North American region holds the largest share of the market due to the increasing burden of traveler’s diarrhea and strong presence of manufacturers in this region. The rising awareness, along with the easy availability of over-the-counter medications, is likely to favor the growth of the traveler’s diarrhea treatment market in North America. However, the side effects associated with the drugs are likely to impede the growth of the market during the forecast period.

Traveler’s Diarrhea Treatment Market 2

Competitive Landscape

The market studied is moderately competitive, and there are several global companies that are operating in this market. The major players in the traveler’s diarrhea treatment market are Bausch Health Companies Inc. (Salix Pharmaceuticals), Bristol-Myers Squibb Company, Cosmo Pharmaceuticals NV, Immuron Limited, Johnson & Johnson, Pfizer Inc., Procter & Gamble, Sanofi SA, and Valneva Canada Inc.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Surge in the Number of Travellers

      2. 4.2.2 Rising Awareness Among Travellers

      3. 4.2.3 Availability of Over-the-counter Medications

    3. 4.3 Market Restraints

      1. 4.3.1 Side Effects Associated With the Drugs

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Drug Type

      1. 5.1.1 Antibiotics

      2. 5.1.2 Anti-diarrheal

      3. 5.1.3 Other Product Types

    2. 5.2 By Distribution Channel

      1. 5.2.1 Hospital Pharmacies

      2. 5.2.2 Retail Pharmacies

      3. 5.2.3 Other Distribution Channels

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Bausch Health Companies Inc. (Salix Pharmaceuticals)

      2. 6.1.2 Bristol-Myers Squibb Company

      3. 6.1.3 Cosmo Pharmaceuticals NV

      4. 6.1.4 Immuron Limited

      5. 6.1.5 Johnson & Johnson

      6. 6.1.6 Pfizer Inc.

      7. 6.1.7 Procter & Gamble

      8. 6.1.8 Sanofi SA

      9. 6.1.9 Valneva Canada Inc.

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Traveler's Diarrhea Treatment Market market is studied from 2018 - 2026.

The Traveler's Diarrhea Treatment Market is growing at a CAGR of 6.8% over the next 5 years.

North America is growing at the highest CAGR over 2021- 2026.

Asia Pacific holds highest share in 2020.

Bausch Health Companies Inc. (Salix Pharmaceuticals), Cosmo Pharmaceuticals N.V., Johnson & Johnson, Pfizer Inc., Procter & Gamble are the major companies operating in Traveler's Diarrhea Treatment Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!